YourChoice Therapeutics, a Berkeley, Calif. startup developing birth control for sperm-producers, banked $15 million in Series A funds, CEO Akash Bakshi tells Axios.
Why it matters: The recent curtailment of women's reproductive rights has placed a renewed focus on the importance of male contraceptives. YourChoice wants to be the first company to enter the clinic with an investigational non-hormonal contraceptive for men, per Endpoints News.
